Header Logo

Connection

Robert Axtell to Cell Proliferation

This is a "connection" page, showing publications Robert Axtell has written about Cell Proliferation.
Connection Strength

0.226
  1. Interleukin-17 accelerates allograft rejection by suppressing regulatory T cell expansion. Circulation. 2011 Sep 13; 124(11 Suppl):S187-96.
    View in: PubMed
    Score: 0.077
  2. CD5-CK2 binding/activation-deficient mice are resistant to experimental autoimmune encephalomyelitis: protection is associated with diminished populations of IL-17-expressing T cells in the central nervous system. J Immunol. 2006 Dec 15; 177(12):8542-9.
    View in: PubMed
    Score: 0.055
  3. Amelioration of ongoing experimental autoimmune encephalomyelitis with fluoxetine. J Neuroimmunol. 2017 12 15; 313:77-81.
    View in: PubMed
    Score: 0.029
  4. Interleukin-16 deficiency suppresses the development of chronic rejection in murine cardiac transplantation model. J Heart Lung Transplant. 2011 Dec; 30(12):1409-17.
    View in: PubMed
    Score: 0.019
  5. Peroxisome proliferator-activated receptor delta limits the expansion of pathogenic Th cells during central nervous system autoimmunity. J Exp Med. 2010 Aug 02; 207(8):1599-608.
    View in: PubMed
    Score: 0.018
  6. Lithium prevents and ameliorates experimental autoimmune encephalomyelitis. J Immunol. 2008 Jul 01; 181(1):338-45.
    View in: PubMed
    Score: 0.015
  7. Critical requirement of CD11b (Mac-1) on T cells and accessory cells for development of experimental autoimmune encephalomyelitis. J Immunol. 2005 Nov 15; 175(10):6327-33.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.